Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 82 of 112, showing 5 Applications out of 560 total, starting on record 406, ending on 410

# Protocol No Study Title Investigator(s) & Site(s)

406.

ECCT/21/12/04   FAST Study
    Assessments of the EFficacy, the onset-of-Action and the Safety of Tot'héma® in adults with moderate iron deficiency anaemia   
Principal Investigator(s)
1. Dr. Francis Xavier Otieno Odawa
Site(s) in Kenya
1. MOI University Teaching and Referral Hospital (Nandi county)
2. UNIM Research and Training Centre (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
 
View

407.

ECCT/25/08/01   MK-8527 as HIV-1 PrEP in Women
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure   Prophylaxis in Women       
Principal Investigator(s)
1. Maricianah Onono
Site(s) in Kenya
1. KEMRI-RCTP KISUMU (Kisumu county)
2. Kargeno Research and Policy Hub KEMRI-CMR KISUMU (Kisumu county)
3. KEMRI-PHRD, Thika (Kiambu county)
4. UW KNH - Rachuonyo County Hospital (Homa Bay county)
 
View

408.

ECCT/12/04/01  
    A double-masked randomised placebo-controlled trial of adjuvant topical 5-fluorouracil (5FU) treatment following surgical excision of ocular surface squamous neoplasia.       
Principal Investigator(s)
1. Stephen Gichuhi
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. PCEA Kikuyu Eye Unit (Kiambu county)
3. Sabatia Eye Hospital (Kakamega county)
4. Kitale District Hospital, Eye Unit (Trans Nzoia county)
5. Homa Bay District Hospital, Eye Unit (Homa Bay county)
 
View

409.

ECCT/13/02/01   AMC 068
    A Randomized Phase II Trial Of Chop Vs Oral Chemotherapy with Concomitant Antiretroviral Therapy in Patients with HIV-Associated Lymphoma in Sub-Saharan Africa   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
View

410.

ECCT/16/08/03   IMPAACT 2001
    A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed project
 
View